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Abstract 
Lactobacilli are commensal gastrointestinal microbes commonly utilized in probiotic 
products, as they are believed to bestow multiple beneficial health effects to the host. Most 
well-studied lactobacilli have been isolated from feces. However, fecal isolates do not 
reflect the microbiota present in the upper gut, since different niches provide different 
microbial habitats. The fistulated dog model facilitates investigation of the microbiota in 
fresh intestinal samples without disturbing the physiology of the canine gut.  
In this study, jejunal lactobacilli from five permanently fistulated beagles were studied. 
We found that facultative Lactobacillus strains were abundant in the jejunal microbiota, 
and L. acidophilus was the dominant species. Repetitive sequence-based polymerase chain 
reaction (rep-PCR) fingerprint profiles of L. acidophilus isolates revealed one 
predominant strain, named LAB20. 
Adhesion is an important factor in bacterial colonization of the host gut. In order to 
adhere, compete, and dominate within the host, numerous bacterial cell-surface factors are 
required to interact with the host mucosa. In this study, the protein profile of LAB20 was 
studied using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
and cell structure was observed via transmission electron microscope (TEM). A surface (S) 
layer protein was revealed from LAB20. S-layer proteins form crystalline arrays of 
proteinaceous subunits in the outer layer of the cell wall and are involved in mediating 
bacterial adhesion to host surfaces. Inverse PCR revealed the DNA sequence of the 
LAB20 S-layer protein,  alignment with other lactobacilli  S-layer protein genes showed it  
was a novel one.  
The discovery of this novel S-layer protein in LAB20 enabled us to develop a strain-
specific detection method. Real-time PCR primers targeting the variable region of the S-
layer protein gene were used to detect and quantify LAB20 in dog intervention studies. 
We found that LAB20 persisted in one dog for over 6 weeks after the feeding period (6 × 
108 CFU daily for 5 days), whereas the five dogs in the other study maintained high 
LAB20 numbers only during the feeding period (108 CFU daily for 3 days). Cultivation of 
fecal samples demonstrated that LAB20 transits through the dog gut and can be identified 
based on colony morphotype. 
TEM revealed a putative extracellular polysaccharide (EPS) layer that comprised 
LAB20’s outermost structure. Using antisense RNA strategy, EPS production was 
manipulated to investigate its potential impact on the ability of LAB20 to adhere to mucus 
and epithelial cells. LAB20 displayed significantly higher adhesion in canine cecal mucus 
relative to the EPS mutant SAA658 and could adhere to Caco-2 and HT-29 epithelial cells. 
This suggests that wild-type EPS plays an integral role in the adhesion of LAB20 in the 
host gut. Moreover, LAB20 attenuated lipopolysaccharide (LPS)-induced interleukin (IL)-
8 production in HT-29 cells, which indicates that LAB20 could be a probiotic candidate 
with anti-inflammatory properties. 
In conclusion, this study investigated the surface structure, persistence, adhesion ability, 
and probiotic potential of LAB20, the dominant L. acidophilus strain in the canine small 
intestine. Our results suggest that LAB20 has potential as a canine probiotic. 
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Introduction 
1. Lactic acid bacteria and probiotics 
1.1 Lactic acid bacteria and their beneficial health effects 
Lactic acid bacteria (LAB) have been used in traditional foods and to carry out 
fermentation since ancient times, when people were not aware of their existence. Naturally 
occurring fermented milk was desired for its pleasant flavor and longer shelf life. By 1857, 
Louis Pasteur had discovered LAB, identifying their role in fermentation. Since then, LAB 
have been isolated using bacterial cultivation techniques and added to food to facilitate 
fermentation. By 1919, Orla-Jensen had classified LAB based on cellular morphology, 
mode of glucose fermentation, growth temperature ranges of growth, and sugar utilization 
patterns; even in the modern taxonomic era, these are considered very important 
classification criteria (Atte Von Wright 2011). The LAB are recognized as Gram-positive, 
low-GC, aerotolerant, generally non-sporulating, non-respiring rods or cocci, which are 
devoid of cytochromes and genuine catalase and produce lactic acid as major carbohydrate 
fermentation product (Atte Von Wright 2011). With the help of molecular biological tools, 
mounting numbers of LAB are being discovered, including non-culturable species. 
According to the current taxonomic classification, LAB belong to the phylum Firmicutes, 
class Bacilli, and order Lactobacillales, and are divided into different families, including 
Aerococcaceae, Carnobacteriacea, Enterococcaceae, Lactobacillaceae, 
Leuconostocaceae, and Streptococcaceae (http://www.uniprot.org/taxonomy/186826). 
LAB are widespread in the environment and predominant in the human and animal 
gastrointestinal tract (GIT). Profound investigations are revealing the beneficial functions 
of  non-pathogenic  LAB.  By  producing  an  array  of  antibacterial  agents,  such  as  acidic  
compounds and bacteriocins, LAB can inhibit spoilage and the growth of pathogenic 
microorganisms (Mills et al. 2011, Dalié et al. 2010). Non-pathogenic LAB can improve 
enzymatic digestion of lactose, and provide vitamins and other essential nutrients (Masood 
et al. 2011). In addition, when interacting with mammalian epithelial cells, non-pathogenic 
LAB  can  enhance  the  immune  system  and  relieve  allergy  symptoms  (van  Baarlen  et  al.  
2013). 
 
1.2 Criteria for a probiotic 
Probiotics are “live microorganisms which when administered in adequate amounts confer 
a health benefit on the host” (Food and Agriculture Organization-WHO 2002). The 
earliest scientific report on probiotic bacteria dates to 1907, when Elie Metchnikoff 
described a correlation between ingestion of the lactic acid-producing bacteria in yogurt 
and enhanced longevity in Bulgarians and other populations (Metchnikoff 1907). An 
increasing number of studies seeks to unveil the mechanisms underlying the beneficial 
effects of probiotics confer to the host and further to investigate the clinical effectiveness 
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of probiotics for various diseases. It has been reported that probiotics may help suppress 
diarrhea, alleviate lactose intolerance and post-operative complications, reduce the 
symptoms of irritable bowel syndrome (IBS), prevent inflammatory bowel disease (IBD), 
and exhibit antimicrobial and anti-colorectal cancer activities (Fontana et al. 2013). 
Probiotics are primarily utilized as food supplement. Despite their putative benefits, the 
European Food Safety Authority (EFSA) has refused hundreds of applications for 
probiotic health claims. This highlights the need to carefully follow regulatory guidelines. 
To provide strong evidence for probiotic efficacy, carefully designed clinical trials with 
sufficient numbers of subjects are needed. Moreover, without a clear understanding of 
probiotics’ mechanisms, the quest to develop these bacteria as clinical drugs will prove 
even more arduous (Sanders et al. 2013). 
To be successfully utilized, probiotics and probiotic candidates must generally possess 
certain characteristics. For example, probiotic candidates should be capable of tolerating 
gastrointestinal conditions (gastric acid and bile) and maintaining themselves in the GIT 
by adhering to mucus or gastrointestinal epithelial cells; they should also confer beneficial 
effects upon the host via microbe-host interactions or the exclusion of pathogens. Given 
these characteristics, some probiotics manage to survive the harsh conditions of the 
stomach and small intestine. After reaching the lower gut, they must conquer the potential 
challenges of a continuously renewed mucus layer, occupied adhesion sites, competition 
from indigenous microbes, and host immune defenses. It is possible that administering a 
sufficient does of probiotics within the proper period could compensate for insufficient 
tolerance or adhesion ability. Thus, the viability and amount of probiotic microorganisms 
are  emphasized  in  the  definition  of  probiotics.  The  essential  function  of  probiotics  is  to  
benefit host health. This could be accomplished by preventing pathogen invasion, 
producing antimicrobial substances like bacteriocins, aiding digestion to provide better 
nutrition, and/or reinforcing immune defenses. In addition, probiotics should be non-
pathogenic, non-toxic and free of significant adverse side effects. From a technical point 
of view, an adequate number of viable cells of the probiotic candidate should be present in 
the delivery product. Therefore, the candidate must be compatible with the product matrix 
and its processing and storage conditions (Fontana et al. 2013).  
When considering the potential health benefits of probiotics, it is notable that probiotic 
effects tend to be strain-specific (Williams 2010). Strain-specificity may depend on the 
structure of the bacterial outer membrane, which determines adhesion capability in the 
host gut, and contains various microorganism-associated molecular patterns (MAMPs) 
that trigger the host immune responses (Konstantinov et al. 2008, Yasuda et al. 2008, 
Grangette et al. 2005). On the other hand, probiotic strains can develop sophisticated 
responses and adaptations in response to the stresses and signals of the host environment. 
The coordinated expression or suppression of genes can alter cellular processes, such as 
cell division, membrane composition and transport systems (Sengupta et al. 2013). 
Modifications to the macromolecular composition of the bacterial cell envelope contribute 
to variation in adhesion capability in different hosts. In addition, since various host species 
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provide different anatomical and physiological environment, and have different dietary 
preferences, a probiotic strain isolated from one host is not necessarily benificial to 
another (Ley et al. 2008, Eckburg et al. 2005, Dogi and Perdigón 2006). Therefore, host 
specificity is considered a desirable property for probiotic bacteria (Salminen et al. 1998, 
Saarela et al. 2000).  
1.3 Mechanisms of probiotic action 
The mechanisms underlying the beneficial effects of probiotics have been studied 
extensively during recent decades, although the history of probiotics dates back to the 
early 1900s (Morelli and Capurso 2012). The putative mechanisms are likely to be multi-
factorial and to differ according to strain. The major mechanisms can be assigned to three 
modes of action. First, probiotics can facilitate a balanced and healthy microbial ecology 
in the GIT via the promoting competitive exclusion of pathogenic bacteria. This may 
occur either through direct inhibitory or competitive activity or through the probiotic 
strain’s influence upon the indigenous commensal microbiota (Lebeer et al. 2008, Corr et 
al. 2009). Second, probiotics can strengthen epithelial barrier function by modulating 
signaling pathways that lead to enhanced mucus or defensin production, preventing 
apoptosis, or increasing tight junction function (Oh et al. 2010). Third, probiotics can 
modulate the immune system of the host, particularly in the small intestine, which harbors 
fewer microorganisms and so provides more adhesion sites for transient probiotics 
(Gareau et al. 2010). By activating dendritic cells (DCs) and interacting with epithelial 
cells and macrophages, probiotics can mediate the release of cytokine, and consequently 
induce  polarization  of  the  T  cell  response  in  the  GIT  (Bron  et  al.  2011,  Coombes  and  
Powrie 2008). Different Lactobacillus strains,  for  example,  can  elicit  a  wide  range  of  
cytokine responses in immune cells (van Baarlen et al. 2013, Maassen et al. 2000) and, 
therefore, regulate the innate and adaptive immune responses. Differences in profiles and 
amounts of host immunostimulatory molecules induced by lactobacilli are suggested to be 
contributed by bacterial strain-specific metabolism and structures (Lee et al. 2013). To 
maintain the delicate balance between necessary and excessive immune defense, 
probiotics should be carefully chosen to improve the host’s ability to fight infections by 
up-regulating immune function or alleviate the onset of intestinal inflammation and 
autoimmunity by down-regulating the immune response. Recent reports have suggested 
that probiotics also have effects on the host’s enteric nervous system and brain signaling 
(Collins et al. 2012) and that by inactivating carcinogens, they decrease cancer risk 
(Sanders  et  al.  2013).  A  summary  of  the  potential  mechanisms  of  probiotic  action  is  
presented in Fig. 1. 
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Figure 1. Potential probiotic mechanisms of action. A) Probiotics provide resistance to pathogen 
colonization by blocking entry into epithelial cells. B) They stimulate goblet cells to release mucus, 
thus strengthening mucus barrier. C) They maintain the intercellular integrity of tight junctions, 
thereby preventing the passage of molecules and pathogen invasion. D) They produce 
antimicrobial factors to kill pathogens. E) They stimulate the immune system by signaling 
dendritic cells to activate pro- or anti-inflammatory responses. F) They initiate TNF production in 
epithelial cells and inhibit or activate nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF?B) to influence cytokine production. Adapted from Gareau et al., 2010. 
 
2. Microbiota of the canine gut 
2.1 Symbiosis of gut microbiota and the host 
Microbes can be found everywhere, from the skin surface to the oral cavity and the urinary 
and  genital  tracts.  The  GIT  harbors  the  largest  microbial  population;  the  human  gut  
contains 40,000 bacterial species (Frank and Pace 2008). This abundance is due to the 
unique physiological characteristics of the GIT, such as being connected to the outer 
environment, containing various nutritional substrates, and having a large surface area. 
The symbiotic relationship between GI microbes and the host is crucial for host health, 
as it is necessary for the proper function of nutritional, immunological, developmental, 
and physiologic processes in animals. Germ-free animals exhibit increased requirements 
for energy and vitamins B and K, decreased immune defenses, impaired intestinal 
structure and morphology, and delayed gastric motility relative to conventional animals 
(Claus et al. 2011, Tlaskalová-Hogenová et al. 2011). The resident microbiota can 
facilitate the digestion of complex carbohydrates, thus providing additional nutrients. The 
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primary end products of the fermentation process, such as acetate, propionate, and 
butyrate (short-chain fatty acid, or SCFA), provide energy for host epithelial cell growth 
and metabolism and also have immuneomodulatory properties. A balanced microbiota can 
prevent pathogen invasion by creating a physiologically restrictive environment, in which 
competition for nutrients and mucosal adhesion sites is stiff. Host genetic background, the 
immune response and dietary preferences can shape individual core microbiomes. Taken 
together, these findings indicate that microbiota is essential and the symbiosis between a 
host and its resident microbiome helps maintain health. 
2.2 Microbiota composition of the canine gut 
Bacterial numbers and composition vary among the compartments of the GIT. In the 
canine stomach (~pH 2 when empty), acidic conditions restrict the bacterial community to 
very low numbers, only 101 to 106 colony forming units (cfu)/g of content survive in this 
harsh environment (Benno et al. 1992, Hooda et al. 2012). Culture-based studies have 
reported that a mixture of aerobes and anaerobes, dominated by Gram-positive bacteria, 
inhabits the stomach. The bile salts and enzymes secreted into the small intestine, which 
facilitate digestion, limit the bacteria in the duodenum and jejunum to around 105 cfu/ml 
of content. Eubacterium, Bacteroides, Clostridium, Fusobacterium, Bifidobacterium, and 
Lactobacillus spp. are predominant in the canine duodenum and jejunum (Hermanns et al. 
1995, Johnston 1999). In the distal small intestine and the large intestine, a more diverse 
microbiota encompassing greater numbers of bacteria (109 to 1010 cfu/g  of  content)  is  
present (Hooda et al. 2012). In 1977, 84 bacterial species within 27 genera were cultivated 
from the ileal, cecal, and colonic content of dogs. The predominant genera included 
Bacteroides, Bifidobacterium, Fusobacterium, Peptostreptococcus, Eubacterium, 
Clostridium, Peptococcus, and Lactobacillus (Davis et al. 1977). 
However, cultivation assays provide limited information about the gut microbiota because 
the majority of microbes cannot be cultured without detailed knowledge of their growth 
requirements. With the aid of molecular-based techniques, GI microbial ecology can be 
studied in more detail (Table 1). Although there have been some previous studies on 
mucosa and digesta samples from various segments of the canine GIT, most studies have 
focused only on bacteria from canine fecal samples (Hooda et al. 2012). 
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Table 1.  Predominant bacterial groups in the canine gastrointestinal tract (presented as percentage of sequences) 
Reference Sample type Method Dog 
number 
(n) and 
age 
Actinobacteria Bacteroidetes Firmicutes Fusobacteria Proteobacteria 
(Hand et al. 
2013) 
Fecal V1-V3* region 16S 
rRNA gene 
pyrosequencing 
n = 11 
1-11 years 
0.33 33.36 15.81 39.17 11.31 
(Garcia-
Mazcorro et al. 
2011) 
Fecal V1-V3 region 16S 
rRNA gene 
pyrosequencing 
n = 12 
0.7-10.2 
years 
0.9-2.0 0.1-1.1 97.5 0.1-0.8 0.1 
(Handl et al. 
2011) 
Fecal V1-V3 region 16S 
rRNA gene 
pyrosequencing 
n = 12 
0.7-10.2 
years 
1.8 2.2 95 0.3 - 
(Swanson 2010) Fecal Whole genome 
pyrosequencing 
n = 12 
1.7 years 
1 37-38 31-35 7-9 13-15 
(Middelbos et 
al. 2010) 
Fecal V3 region 16S rRNA 
gene pyrosequencing 
n = 6 
1.7 years 
0.8-1.4 32-34 15-28 24-40 5-6 
(Suchodolski et 
al. 2009) 
Jejunal mucosa 
samples 
16S rRNA gene 
pyrosequencing 
n = 5 
2 years 
11.2 6.2 15 5.4 46.7 
(Xenoulis et al. 
2008) 
Duodenal biopsies 16S rRNA gene 
pyrosequencing 
n = 9 
2.7-6years 
1.0 11.2 46.4 3.6 26.6 
(Suchodolski 
2008) 
Duodenum, 
jejunum, ileum 
and colon contents 
V1-V3 region 16S 
rRNA gene 
pyrosequencing 
n = 6 
3.6-7 years 
- 12.4 47.7 16.6 23.3 
 
 
                                               
* V1-V3 are hypervariable regions on 16S rRNA, which enable distinguish of bacterial species. 
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2.3 Probiotic intervention studies on dogs 
2.3.1 Effects on diarrhea and microbiota shifts 
Animal models and human studies have been used to investigate the impact of probiotics upon 
many gastrointestinal diseases, including IBS, IBD, infectious diarrhea, small intestinal bacterial 
overgrowth (SIBO), and antimicrobial-associated and nosocomial diarrhea (Sanders et al. 2013, 
Gareau et al. 2010). Findings on the efficacy of probiotics for bowel diseases have been inconsistent, 
due to variation in the strains and doses studied and small or heterogeneous trial populations. 
Additionally, in the absence of generally agreed upon biomarkers for certain diseases, such as IBS 
and allergy, it is difficult to obtain comparable data from various intervention studies. However, 
promising results continue to encourage researchers to study probiotic functions. 
Many gastrointestinal diseases are associated with diarrhea. Diarrhea results from the 
stimulation of mucosal fluid secretion when mucosal absorptive capacity is diminished. It can be 
stimulated by dysfunctional immune responses or enterotoxins released from microbes. Canine 
intervention studies of probiotics effects on clinical diarrhea are limited relative to human clinical 
trials. In one randomized, double-blind parallel study, ingestion of a probiotic cocktail reduced 
convalescence time for acute, self-limiting diarrhea in dogs (the period of abnormal stools was 
reduced  from  2.2  to  1.3  days)  (Herstad  et  al.  2010).  In  a  dog  model  of  non-specific  dietary  
sensitivity (NSS), L. acidophilus strain DSM 13241 improved fecal consistency, fecal dry matter, 
and defecation frequency and increased fecal lactobacilli and bifidobacteria while decreasing the 
number of C. perfringens and Escherichia spp. (Pascher et al. 2008). Another study reported that, 
compared to a placebo, the canine-derived probiotic B. animalis strain AHC7 significantly 
shortened the resolution rate of acute idiopathic diarrhea in dogs (Kelley et al. 2009). In addition to 
clinical signs evaluation, intestinal cytokine patterns have been studied in dogs with food-
responsive diarrhea (FRD). However, intestinal cytokine patterns were not associated with the 
improved clinical features observed after treatment with a probiotic cocktail (Sauter et al. 2006). In 
another study with large sample size, the ability of the probiotic E. faecium SF68 to reduce the 
duration of chronic diarrhea was investigated in 217 cats and 182 dogs in an animal shelter. While 
cats fed SF68 had fewer episodes of diarrhea, no significant reduction was found in dogs (Bybee et 
al. 2011). Due to the inadequacy of the research base, our knowledge of the effects of probiotics in 
dogs with clinical symptoms is too restricted to draw reliable conclusions. 
 Probiotic intervention studies have also been conducted on healthy dogs, to investigate 
probiotic-induced shifts in the microbiota. Most studies have found a decrease in potentially 
pathogenic bacteria and an increase in LAB. In one study, dietary supplementation with B. 
amyloliquefaciens CECT 5940 and E. faecium CECT 4515 had no effect on fecal scores or 
digestibility  coefficients  compared  with  the  control  group,  but  it  is  possible  that  it  stabilized  the  
fecal microbiota by decreasing pathogenic Clostridia (González-Ortiz et al. 2013). In another study, 
probiotic L. acidophilus strain DSM13241 increased the number of fecal lactobacilli and decreased 
the number of Clostridia. In addition, it improved immune function in dogs by increasing 
hematocrit levels, hemoglobin concentrations, serum IgG levels, and the number of red blood cells, 
neutrophils, and monocytes (Baillon et al. 2004). In addition to culture-based studies, 
pyrosequencing has been used to study the fecal microbiota of healthy cats and dogs (Garcia-
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Mazcorro et al. 2011). After probiotic feeding, no changes in the predominant bacterial phyla in dog 
feces or no significant changes in immune markers were found. However, an increased abundance 
of probiotic bacteria was found in the feces, consistent with culture-based analyses. Some canine-
derived strains that have potential as probiotics have also been investigated in intervention studies. 
The canine feces-derived strain L. animalis LA4 led to an increase in fecal lactobacilli while 
reducing enterococci (Biagi et al. 2007). Canine-derived strain L. fermentum AD1  increased  the  
number of fecal lactobacilli and enterococci as well as total proteins and lipids, and reduced serum 
glucose levels (Strompfová et al. 2006). Another study reported that the canine colon-derived strain 
B. animalis AHC7 significantly reduced carriage of Clostridia in dogs (O'Mahony et al. 2009). One 
study of canine fecal LAB administration resulted in jejunal bacterial population changes, and an 
indigenous LAB strain became dominant after probiotic feeding had ended (Manninen et al. 2006).  
Prebiotics are substrates that can facilitate the growth and function of probiotics when used with 
probiotics, this combination is termed symbiotic. Symbiotic combinations have rarely been studied 
in dogs. In one study, L. fermentum CCM 7421 was administrated with inulin. The fecal microbiota 
of dogs fed with this combination contained less Clostridia and higher numbers of LAB than that of 
a control group. However, the inulin supplement did not intensify probiotic efficacy (Strompfová et 
al. 2012). One obstacle to using probiotics is that probiotic candidates generally cannot persist in 
the GIT after administration stops. In one study, however, the canine-derived strain E. faecium EE3 
persisted in dog feces for 3 months after a 1 week administration, accompanied by decreased 
Staphylococci and Pseudomonas-like bacteria and increased LAB (Marcináková et al. 2006). 
2.3.2 Effects on general immune function 
Probiotics can benefit the host by interacting with the intestinal mucosa, thus modulating the 
host immune system. Several probiotic effector molecules are involved in immune interactions, 
including bacterial cell wall component, such as peptidoglycan, polysaccharides, and specific 
proteins (Klaenhammer et al. 2012). Furthermore, probiotics can indirectly influence the gut 
immune response by affecting the endogenous commensal microbiota. The mechanisms underlying 
the probiotic-regulated immune response have been studied primarily using in vitro cell-culture 
models that may not accurately reflect in vivo conditions.  
Compared  to  human  trials,  many  fewer  studies  have  explored  the  effects  of  proibiotics  on  
immune function in dogs. One study demonstrated that supplementation with E. faecium SF68 
increased fecal IgA and canine distemper virus (CDV) vaccine-specific circulating IgG and IgA; 
this was the first time that dietary probiotic LAB were shown to enhance specific immune functions 
in young dogs (Benyacoub 2003). A recombinant strain of L. casei engineered to produce 
biologically active canine granulocyte macrophage colony stimulating factor (cGM-CSF) increased 
serum canine corona virus (CCV)-specific IgG (Chung et al. 2009). 
2.3.3 Effects on skin disease 
Probiotic studies on canine skin problems are rare. Marsella et al. have studied the effects of L. 
rhamnosus strain GG upon atopic dermatitis (AD) in atopic beagles. The results indicate that L. 
rhamnosus strain GG decreased allergen-specific IgE (Marsella 2009). A follow-up study, three 
years after L. rhamnosus strain GG exposure had been discontinued, found that exposure to 
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probiotics in early life had long-term clinical and immunological effects in this canine model of AD 
(Marsella et al. 2012). Later, expression of filaggrin, a key protein for the skin barrier function by 
preventing percutaneous transfer of allergens, was used as a biomarker for AD. Probiotic exposure 
did not alter filaggrin expression in canine skin biopsy samples (Marsella et al. 2013). 
2.3.4 Effects on parasites 
The effects of probiotics on eukaryotic pathogens have been little studied. Recent studies have 
shown that gut commensal microflora can interfere with the life cycle of the intestinal parasitic 
nematode Trichuris muris and provide indirect protective immunostimulation against non-gut 
parasites, such as Toxoplasma gondii (Benson et al. 2009). Probiotic intervention studies to reduce 
the viability or infectivity of various eukaryotic pathogens have been conducted using cell culture 
and animal models, primarily mice (Travers et al. 2011). The results have been inconsistent, with 
protection against parasites varying according to the probiotic strain tested. In the only dog model, 
Simpson  et  al.  studied  to  date,  Simpson  et  al.  (Simpson  et  al.  2009)  found  that  E. faecium SF68 
failed to affect giardia cyst shedding or the innate and adaptive immune responses in dogs with 
chronic, naturally acquired, subclinical giardiasis. 
3. Adherence of Lactobacillus in the gastrointestinal tract 
Lactobacilli are present in variable amounts throughout the human GIT; they represent about 1% 
of microorganisms in the nutrient-rich luminal content but only 0.01% of total culturable counts 
from feces  (Dal  Bello  et  al.  2003,  Tannock et  al.  2005).  The  proportion  of  lactobacilli  also  varies  
significantly among individuals (Maukonen et al. 2008). Lactobacilli are the most often used 
probiotics in foods, fermentation, and pharmaceutical preparations (Sanders 1999). It has been 
reported that they adhere to and interact with host gastrointestinal surfaces via various bacterial 
cellular structures, some of which are also involved in mediating the host immune response 
(Strompfová et al. 2006). Various in vitro model systems are utilized in routine adhesion 
experiments, such as Caco-2 or HT-29 human-derived colorectal adenocarcinoma cells (von Kleist 
et al. 1975), immobilized intestinal mucus (Roos and Jonsson 2002, Vesterlund et al. 2005), and 
immobilized extracellular matrices (Lindgren et al. 1992). Detection methods such as quantitative 
culturing (Mack et al. 1999), microscopic enumeration (Tuomola and Salminen 1998), 
radiolabelling (Bernet et al. 1993) immunological detection, and fluorescent in situ hybridization 
(FISH) provide good resolution in adhesion assays (Maré et al. 2006).  
3.1 The intestinal mucosa  
The intestinal mucosa consists of a one-cell thick epithelial layer and the underlying lamina propria. 
The lamina propria is a sterile connective tissue that contains various immune cells. The epithelial 
layer separates the highly colonized intestinal lumen from the lamina propria, preventing the 
passage of “non-self” entities, such as bacteria and food components, from the former to the latter. 
The epithelial layer induces pro-inflammatory host responses while maximizing nutrient absorption 
via its large surface area (O'Hara and Shanahan 2006). More than 80% of intestinal epithelial cells 
are columnar cells involved in nutrient absorption and metabolic functions. Tight junctions maintain 
a selective impermeable barrier between neighboring epithelial cells (Balda and Matter 2008). In 
addition, Paneth cells and goblet cells in the epithelium support the integrity of the epithelial barrier 
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via innate immune defenses (McCracken and Lorenz 2001). For example, Paneth cells at the bottom 
of intestinal crypts produce various antimicrobials, such as defensins and lysozyme, to prevent close 
contact between microorganisms and the crypt’s proliferative cells (Ouellette and Bevins 2001, 
Bevins and Salzman 2011). Goblet cells produce a complex mixture of glycosylated proteins 
(mucins), thus forming a protective mucus layer on the epithelium, that prevents direct contact with 
luminal microorganisms (McCracken and Lorenz 2001, Bevins and Salzman 2011, Wells et al. 
2011). The composition of the mucus layer is dynamic, reflecting a balance between production, 
degradation, and physical erosion (Sengupta et al. 2013). The mucus layer can shorten the bacterial 
residence time in the GIT, thereby preventing the colonization of epithelial cells by undesired 
bacteria. On the other hand, mucus can serve as a habitat for commensal bacteria, such as 
lactobacilli (Kirjavainen et al. 1998, Ouwehand et al. 2001, Servin 2004). The antimicrobial-
saturated mucus layer, along with epithelial cells and immune defenses, establish the epithelial 
barrier that is critical to intestinal health. 
3.2 Cell surface structures of Lactobacillus associated with adhesion 
The fundamental structure of the lactobacillar cell envelope consists of a bilipid plasma membrane 
embedded with proteins and surrounded by a cell wall. The bacterial cell wall consists of multiple 
layers  of  peptidoglycan  (PG)  decorated  with  teichoic  acids  (wall  teichoic  acids,  WTAs,  and  
lipoteichoic acids, LTAs) and proteins anchored to the cell wall through various mechanisms. 
Sometimes polysaccharides, proteinaceous filaments called pili, and an additional paracrystalline 
layer of surface (S)-layer proteins that encompasses the PG layer are present as well (Sengupta et al. 
2013). These components vary in terms of appearance and structure among different bacterial 
strains. In lactobacilli, they display species and strain-specific characteristics, playing crucial roles 
in host-microbe interactions and adaptation to the changing host environment. Moreover, the 
surface properties of lactobacilli can be modified in response to environmental challenges (Taranto 
et al. 2003, Fozo et al. 2004). 
3.2.1 Mucus binding proteins 
Lactobacillus adhesion to mucus involves mucus-binding proteins (Mubs). Thus far, functionally 
characterized lactobacilli mucus adhesins include the Mub of L. reuteri 1063 (Roos and Jonsson 
2002), the Mub of L. acidophilus NCFM (Buck et al. 2005), and the lectin-like mannose-specific 
adhesion (Msa) of L. plantarum WCFS1 (Pretzer et al. 2005). These three Mubs share a similar 
mucus-binding domain that has also been identified in several species of LAB, implying the domain 
is a LAB-specific functional unit (Sengupta et al. 2013). However, high levels of genetic 
heterogeneity exist among Mubs of different strains, resulting in strain-specific diversity in the 
ability of bacteria to adhere to mucus (Mackenzie et al. 2010). Proteins containing Mub repeats are 
abundant in lactobacilli that inhabit the GIT, suggesting that the Mub repeat is a functional unit that 
may be an evolutionary adaptation for survival in the GIT. Mub and Mub-like proteins have also 
been shown to contribute to autoaggregation in L. reuteri strains (Mackenzie et al. 2010). 
3.2.2 Sortase-dependent proteins 
In Gram-positive bacteria, a subgroup of surface proteins that contain the C-terminal motif LPxTG 
is recognized by sortase (SrtA). Cleavage between the T and G residues results in the formation of a 
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covalent link between the threonine carboxyl group and an amino group provided by cell wall 
cross-bridges of peptidoglycan precursors. The resulting surface protein is incorporated into the cell 
envelope and displayed on the bacterium’s surface (Marraffini et al. 2006). These surface proteins 
are commonly called sortase-dependent proteins. Functionally characterized sortase-dependent 
proteins include the Mub of L. reuteri 1063 (Roos and Jonsson 2002), the Msa of L. plantarum 
WCFS1 (Pretzer et al. 2005), and the Mub of L. acidophilus NCFM (Buck et al. 2005), all of which 
are mucus adhesins. The lipoprotein signal peptidase (LspA) of L. salivarius UCC118 and the 
lactobacillus epithelium adhesion (LEA) of L. crispatus ST1 are reported to mediate adhesion to 
epithelial cells (Claesson et al. 2006, van Pijkeren et al. 2006) (Edelman et al. 2012). Although most 
sortase-dependent proteins of lactobacilli are reported to have capacity to bind to mucus, they do 
not necessarily have affinity to mucus components (Vélez et al. 2007). More studies will be needed 
to reveal the function of putative lactobacilli sortase-dependent proteins. 
3.2.3 Surface layer proteins  
The S-layer proteins of lactobacilli generally self-assemble into monomolecular crystalline arrays 
exhibiting a morphologically similar lattice structure; they represent 10-15% of total proteins in the 
bacterial cell wall (Antikainen et al. 2002, Jakava-Viljanen et al. 2002, Åvall-Jääskelainen and 
Palva 2005). S-layers can be found in several species of Lactobacillus, as well as in other bacterial 
species and Archaea. The biological functions of S-layers are diverse, ranging from serving as a 
protective coat to providing molecule and ion traps, surface recognition of hydrolase, and adhesion 
sites  (Hynönen  and  Palva  2013a).  Although  the  biological  functions  of  most  S-layers  remain  
unknown, some Lactobacillus S-layer proteins, including the CbsA of L. crispatus JCM 5810 (Toba 
et al. 1995, Sillanpää et al. 2000, Antikainen et al. 2002), the Slp of L. helveticus R0052 (Johnson-
Henry 2007), the SlpA of L. brevis ATCC 8287 (Vidgren 1992, Åvall-Jääskelainen 2002, Hynönen 
2002), and the SlpA of L. acidophilus NCFM  (Buck  et  al.  2005)  have  been  shown  to  mediate  
adhesion to epithelial cells, and extracellular matrices (Vidgrén et al. 1992, Hynönen et al. 2002, de 
Leeuw et al. 2006). In addition, it has been suggested that S-layer proteins have a lectin-like ability 
to interact with glycoproteins and polysaccharides, thus influencing interactions between 
lactobacilli and other microorganisms (Golowczyc et al. 2009). 
3.2.4 Proteins mediating adhesion to the extracellular matrix 
The extracellular matrix (ECM) composed of various proteins, including laminin, collagen, and 
fibronectin, surrounds intestinal epithelial cells and is referred to as connective tissue. When the 
mucosa is damaged, the ECM can be exposed to and colonized by undesirable microbes (Styriak et 
al. 2003). Some lactobacilli have the ability to adhere to this matrix and can occupy binding sites in 
the gut, competing with pathogens for receptors (Styriak et al. 1999, Neeser et al. 2000, Lorca et al. 
2002). The fibronectin-binding protein (FbpA) of L. acidophilus NCFM and the collagen-binding 
protein (CnBP) of L. reuteri NCIB11951 may facilitate binding of these strains to ECM (Aleljung 
et al. 1994) (Buck et al. 2005). Other examples of lactobacilli binding to collagen include the 
previously discussed S-layer proteins of L. crispatus (CbsA) (Antikainen et al. 2002), and L. brevis 
ATCC 8287 (SlpA) (Hynönen et al. 2002). 
3.2.5 Nonprotein adhesins (LTA and EPS) 
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Teichoic acids are the second major component of the lactobacillus cell wall, accounting for up to 
half of the cell wall’s dry weight (Kleerebezem et al. 2010). They are anionic polymers made up of 
repeating units of glycerol- or ribitol-phosphate they can be covalently linked to PG, in the case of 
WTA  or  attached  to  the  cytoplasmic  membrane  via  lipid  anchors,  in  the  case  of  LTA.  LTAs  
contribute to the cell wall with their hydrophobic character, influencing its adhesiveness. TAs vary 
in terms of sugars and number of phosphate residues. The variation reflects multiple-factors, such as 
the strain species, stage or rate of growth, and nutrient availability in the medium (Delcour et al. 
1999). In L. johnsonii NCC 533, LTA has been reported to mediate adhesion to Caco-2 cells 
(Granato et al. 1999). 
Cell wall polysaccharides are neutral polysaccharides that can form an outer capsule by 
covalently binding to PG (in the case of capsular polysaccharide, CPS), loosely associating with the 
cell wall (in the case of wall polysaccharide, WPS) or being released into the extracellular medium 
(in the case of extracellular polysaccharides, EPS). However, it is difficult to provide distinct 
definitions for the various classes of cell wall polysaccharides. In lactobacilli, EPS generally refers 
to extracellular polysaccharides attached to the cell wall or released into the surrounding medium 
(Sengupta  et  al.  2013).  The  composition  of  EPSs  varies  with  regard  to  the  nature  of  the  sugar  
monomers as well as their linkages, distribution, and substitution. This variability contributes to the 
structural variety observed in the Lactobacillus cell wall (Reeves et al. 1996, Wicken et al. 1983). 
EPS usually consists of heteropolysaccharides, although some strains of lactobacilli are capable of 
synthesizing homopolysaccharides (Tieking et al. 2005). Some polysaccharide chains are 
components of glycoproteins, providing anchorage for S-layer proteins and contributing extra 
complexity to bacterial cell wall architecture (Francius et al. 2008). The specific functions of EPS in 
the cell wall remain unclear, although it has been reported to mediate interactions between 
lactobacilli and the environment and to promote bacterial adhesion and biofilm formation (Lebeer et 
al. 2011). In L. acidophilus CRL639, adhesion to components of the ECM has been associated with 
production of different types of EPS (Lorca et  al.  2002).  The carbohydrates on the L. acidophilus 
BG2FO4 cell wall have been reported to be partly responsible for adhesion of this strain to Caco-2 
cells and to mucus secreted by HT29-MTX cells (Coconnier et al. 1992). 
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Aim of the study 
The main objectives of this study were to isolate potential probiotic strain for canine use. 
Lactobacillus strains from canine jejunal chyme were investigated (I). By developing a strain-
specific detection method (II), one particular strain L. acidophilus LAB20 was further studied for its 
properties that facilitate it to be predominant in canine lactobacilli (III and IV). The detailed 
objectives of the research were to: 
 
1. Exploit the Lactobacillus community in the jejunal chyme of fistulated dogs. The dominant strain 
(LAB20) was selected for further study of its cellular surface structure, which may facilitate its 
dominance in the canine gut. 
 
2.  Detect  LAB20  from  the  feces  of  dogs  to  which  LAB20  has  been  orally  administered,  using  
strain-specific detection primers in real-time PCR.  
 
3. Evaluate whether LAB20 has the capacity to adhere to mucus or intestinal cells and potential 
immunomodulatory effects.  
 
4. Modulate the extracellular polysaccharide (EPS) production of LAB20 using antisense RNA, to 
investigate its effect on bacterial binding ability.  
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Materials and Methods 
1. Strains, primers, and plasmids 
The strains used in this study are presented in Table 2, PCR primer sequences are listed in Table 3, 
and bacterial plasmids are listed in Table 4.  
 
Table 2. Bacterial strains in this study. 
Strain Reference/Source Used in 
Lactobacillus acidophilus LAB20 This work I, II, III, IV 
Lactobacillus acidophilus LAB48 Abbas Hilmi et al., 2007 I 
Lactobacillus acidophilus HAMBI80 HAMBI I 
Lactobacillus acidophilus 74-2 Danisco Ltd. I, II 
Lactobacillus acidophilus ATCC4356 ATCC I 
Lactobacillus rhamnosus Lc-705 Valio Ltd. II 
Lactobacillus rhamnosus GG Valio Ltd. II, IV 
Lactobacillus crispatus ATCC33820 ATCC II 
Lactobacillus crispatus 119MI Cultor Ltd. II 
Lactobacillus helveticus 53/7 Valio Ltd. II 
Lactobacillus reuteri CHCC1956 CHCC II 
Lactobacillus salivarius ATCC11742T ATCC II 
Lactobacillus acidophilus HAMBI1448 HAMBI II 
Lactococcus lactis ATCC7962 ATCC II 
Escherichia coli TG-1 Genesit Ltd. I, II 
Lactobacillus acidophilus SAA658 This work IV 
ATCC: American Type Culture Collection. HAMBI: Culture collection from the University of Helsinki, 
Faculty of Agriculture and Forestry, Division of Microbiology 
 
Table 3. Sequences of PCR primers used in this study.  
Primer name Sequence 5’-3’ Used in  
pA AGAGTTTGATCCTGGCTCAG I 
pE 
(GTG)5-primer 
CCGTCAATTCCTTTGAGTTT 
GTGGTGGTGGTGGTG 
I 
I 
Usl-1 forward GAATYGTKAGCGCTSCTGCTGC I 
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Usl-2 reverse GTAAACGTAWGCGTTGTGCTTC I 
UpInverse 1 TTTAGACCAATACGGTAACG I 
UpInverse 2 AGCACCTGCACCAGTTAAGTC I 
Inverse 1 TACATCAACGCTGCTAACATC I 
Inverse 2 TTTAACGCTGTCAGTACCAA I 
RT1 TCAGGCTACACTACTATT II, III 
RT2 
EPF 
EPR 
EAF 
EAR 
CTACACCAGTAAGTTCAA 
AAAGCGCGCTGCTTGTGGGGGT 
ATCATTTTTCCTCTTACCCTGATTCATATTGTACTAAC 
AGTACAATATGAATCAGGGTAAGAGGAAAAATGAT 
TTTGATATCTGATAAACATACCGCCCATGC 
II, III 
IV 
IV 
IV 
IV 
 
 
Table 4. Plasmids used in this study. 
Plasmid Relevant properties Reference Used in 
pLEB767 3.1 kb, pBluescript + partial S-layer gene of 
LAB20, Ampr 
This study I 
pLEB579 2.9 kb, Cloning vector, Ermr Beasley et al. 2004 III 
 
2. Methods 
The methods used in this study are presented in Table 5. Detailed descriptions of the methods are 
presented  in  the  Materials  and  Methods  sections  of  publications  I-II,  and  manuscripts  III  and  IV.  
Unpublished methods are presented in chapters 2.1-2.4. 
 
Table 5. Methods used in this study. 
Method Used and 
described in  
Reference 
Strain isolation I, II, III Shea Beasley et al. 2004 
Basic DNA techniques, including PCR, 
enzyme modifications, electrophoresis, 
plasmid isolations 
I, II, III, IV Ausubel et al. 1987; 
Sambrook et al. 1989; 
Anderson and McKay 
1983. 
Partial 16S rRNA gene sequencing I Edwards et al. 1989 
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SDS PAGE II Sambrook et al. 1989 
TEM IV  
N-terminal sequencing II  
Rep-PCR I  
Genomic DNA isolation I, II, III, IV Anderson and McKay 
1983 
Fermentation of milk II, III  
Real-time PCR 
Overlap PCR 
Attenuation assay and ELISA 
Cell and mucus adhesion assay 
II, III 
IV 
IV 
IV 
 
 
2.1 Phenotypic microarray test. 
The effect of pH on the growth profile of LAB20 was determined using the phenotypic microarray 
(PM) system from Biolog (Hayward, CA). Reagents, media, and PM10 MicroPlates were purchased 
from Biolog, and PM experiments were conducted according to the manufacturer’s instructions. PM 
plates were incubated at 37°C and recorded for 60 h. Data from a single experiment were analyzed 
with Omnilog-PM software from Biolog. 
2.2 Growth rates. 
The pH of mLBS broth was adjusted to 5.0, 6.5, 7.0, 8.0, or 9.0 with HCl or NaOH, and then media 
was filtered with a 0.45 µm filter. In each well of a Honeycomb plate (Growth Curves Ltd, Helsinki 
Finland), 300 µl broth was inoculated with 6 µl LAB20 overnight culture, except for controls wells, 
which contained only broth. Three replicates were performed for each treatment group. The 
Honycomb plate was incubated in Microbiology Reader Bioscreen C (Growth Curves Ltd, Helsinki 
Finland) at 37°C for 30 h. Growth was measured every 40 min by optical density (OD) at 600 nm. 
Maximum cell density (ODmax) was determined when growth curves reached stationary phase.  
2.3 Transmission electron microscopy. 
Bacterial cells from overnight LAB20 culture were fixed using 2.5% glutaraldehyde in 0.1 M 
sodium cacodylate buffer at room temperature for one hour. Samples were then stained via 
incubation in 2% glutaraldehyde, 0.1% ruthenium red in 0.1 M sodium cacodylate at 4°C for one 
hour. After washing with 0.1 M sodium cacodylate buffer, the samples were post-fixed by 
incubation in 2% osmium tetroxide containing 0.1% ruthenium red in sodium cacodylate buffer for 
3 hours at room temperature. Samples were washed again with 0.1 M sodium cacodylate prior to 
dehydration with a series of ethanol solutions increasing from 50% to 100%, and finally with 100% 
acetone. Then they were plastic embedded by successive incubation in 30% Epon in acetone for 3 
hours, 70% Epon in acetone overnight, 100% Epon for 3 hours repeated twice, and finally fresh 100% 
Epon resin.  After polymerization of the resin (60°C for 18 hours) ultrathin sections (60 nm) were 
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cut. For negative staining, an overnight culture of LAB20 was loaded to a copper grid, and negative 
staining was performed with phosphotungstic acid (2% [wt/vol] in H2O). Sections post-stained with 
uranyl acetate and lead citrate were imaged using a TecnaiF20 transmission electron microscope 
(TEM, FEI Corp.) operating at 200 kV.  
2.4 Expression analysis of LAB20 genes associated with binding when grown in the presence 
of mucin 
Two hundred µl LAB20 overnight culture was inoculated to 10 ml mLBS7 broth supplemented 
with 0, 0.05, or 0.25% procine mucin (Sigma) and grown at 37°C overnight. Total RNA was 
extracted from 10 ml 0%, 0.05%, and 0.25% mucin-cultured LAB20 (GeneJET RNA Purification 
Kit,  Thermo  Scientific,  Finland).  Then  the  first  strand  of  cDNA  was  synthesized  using  reverse  
transcription  PCR  (RT-PCR;  RevertAid  RT  kit,  Thermo  Scientific,  Finland).  cDNA  was  diluted  
1:10 and used as a real-time PCR template, with a Tm of 58°C. The independent-samples t test was 
used to determine statistically significant differences (P < 0.05). The results of technical replicates 
are shown as means ± standard deviations. 
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Results and Discussion 
1. Prevalence of L. acidophilus in canine jejunal chyme (I) 
1.1. Lactobacilli in the jejunal chyme of five fistulated beagles 
Due to difficulties in sampling the intestine, most host-derived probiotic strains are isolated from 
fecal samples (Baillon et al. 2004). However, it has been reported that the fecal microbiota are 
different from the upper intestinal microbiota, both in terms of species composition and cell 
numbers (Mentula et al. 2005). To study the prevalence of lactobacilli in the canine small intestine 
and identify potential probiotic candidates that could dominate in the canine gut, we used the jejunal 
fistulated dog model. The fistulated dog model enables investigation of the intestinal microbiota 
without disturbing intestinal motility or microflora (Harmoinen et al. 2001).  
Jejunal chyme specimens from five dogs (A, B, C, D, and E) were plated on nutrition agar (NA) 
and mLBS plates, and then incubated aerobically. With a view toward the convenient manufacture 
of probiotics, aerobic/facultative anaerobic bacteria were chosen for study. The total jejunal bacteria 
was around 3 × 107 CFU/ml in each dog, whereas the number of lactobacilli selected with mLBS 
plates  varied  (from  7  ×  104 to  8  ×  107 CFU/ml) (Fig.1 of Study I). Previously, the microbial 
composition in canine jejunal chyme was had been studied by Mentula et al. (2005). In their study, 
only 30 CFU/g lactobacilli were found, and in only one canine jejunal sample of 22 dogs. The small 
number of lactobacilli detected may be a result of sample treatment, as they plated samples that had 
been frozen without adding cryoprotectants. In our study, fresh jejunal chyme was plated within 3 
hours, thus avoiding freeze damage to bacterial cells. In addition, we utilized less selective mLBS 
plates, which resulted with abundant Lactobacillus isolates. 
Approximately 20 colonies from mLBS plate of each dog were identified using partial 16S 
rRNA gene sequencing, yielding a total of 74 isolates that clustered into four species. L. acidophilus 
was dominant in four dogs, and isolates from dogs D and E were confined to L. acidophilus strains. 
L. murinus was  dominant  in  dog  C  and  also  found  in  dogs  A  and  B.  However,  L. johnsonii was 
detected only in dog A, and only minor L. reuteri counts  were  identified  in  dogs  B  and  C.  The  
results indicate that facultative jejunal lactobacilli consist of a limited number of species (Table 1 of 
Study I). In another study that used a fistulated dog model (Rinkinen et al. 2004), L. murinus and L. 
reuteri were also detected, whereas S. alactolyticus was the dominant culturable LAB. The small 
number  of  bacterial  species  in  the  small  intestine  could  result  from  the  challenges  posed  by  bile  
salts and enzymes and the rapid transit time of the intestinal contents. 
1.2. Rep-PCR typing of isolated L. acidophilus strains 
To analyze variation among the L. acidophilus strains  isolated,  rep-PCR  with  the  (GTG)5-primer 
pair were performed. Fifty-one fragment profiles were generated from 54 L. acidophilus jejunal 
isolates. None of the isolates had profiles identical to L. acidophilus strains from other host (Fig2. 
of Study I). Further, in eight distinct profiles identified, the majority of isolates presented the same 
fragment profile, suggesting there could be a single dominant L. acidophilus strain in the jejunum. 
This representative strain (shown in lane A13 of Fig2. in Study I) was named as LAB20 and 
selected for further study. 
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1.3. LAB20 growth optimization (Unpublished) 
To  optimize  the  growth  condition  for  LAB20,  the  Biolog  PM  test  was  used.  Although  some  
substrates, such as sucrose and L-Lyxose, enhanced LAB20 growth, the most dramatic increase in 
growth occurred in response to pH (Fig.  1).  Bacterial  density  and  the  growth  rate  of  LAB20  
gradually increased with pH (from 3.5 to 10.0), peaking at pH 9.5. This suggests that LAB20 
cultivation could be optimized by adjusting the pH in the mLBS medium. However, in the PM test, 
LAB20  was  grown  in  a  defined  culture  formula,  not  in  mLBS.  Therefore,  the  optimal  pH  (9.5)  
identified using the microarray may not be the optimal pH for LAB20 growth in mLBS medium. 
 
 
Figure. 1  Growth of LAB20 in PM10 microplates (Biolog). Data are presented in a PM kinetics graph 
for different pHs. A01 = pH 3.5, A02 = pH 4.0, A03 = pH 4.5, A4 = pH 5.0, A05 = pH 5.5, A06 = pH 6.0, 
A07 = pH 7.0, A08 = pH 8.0, A09 = pH 8.5, A10 = pH 9.0, A11 = pH 9.5, and A12 = pH 10.0. 
 
To test the effect of pH upon LAB20 growth in mLBS medium, broth of varying pH was 
inoculated with LAB20 and incubated using the Bioscreen system (Fig.  2). Growth curves for 
LAB20 grown in mLBS medium with different initial  pHs were obtained. Broth with a pH of 7.0 
yielded the fastest growth and highest cell density (i.e. the shortest lag phase and exponential phase 
time) at OD 600 nm. In contrast, broth at pH 5.0, 6.2, 8.0 and 9.0 did not represent optimal growth 
conditions. Therefore, mLBS at pH 7.0 was used as the optimized LAB20 growth medium. 
 
 
 
 
Figure.  2 Growth curves for 
LAB20 in mLBS broth with 
different  initial  pHs,  5.0  (?),  
6.2 (?), 7.0 (?), 8.0 (×), 9.0 
(+). 
 
2. Surface structures of LAB20 (II) 
2.1. Identification of S-layer protein as a surface component of LAB20 
Surface structures could play an essential role in LAB20’s dominance in the canine small intestine, 
since bacterial adhesion in the gut is most likely associated with bacterial surface structures 
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(Jakava-Viljanen and Palva 2007, von Ossowski et al. 2011, Lebeer et al. 2010). Therefore, LAB20 
protein profiles were studied, both for whole cells and LiCl-extracted proteins. The protein profiles 
revealed one major band with a molecular mass of approximately 50 kDa (Fig. 1 of Study II). The 
proportion of the protein in the profile and its putative extracellular location indicated that it could 
be an S-layer protein, which typically is extracted using LiCl and represent 10-15% of proteins in a 
profile (Frece et al. 2005).  
To  verify  the  presence  of  the  putative  S-layer  protein  on  LAB20  cells,  the  N-terminus  of  the  
protein was sequenced. Its NH2-terminal sequence (Ala-Asp-Ala-Thr-Thr-Thr-Thr-Thr-Ala) was 78% 
identical to that of the L. crispatus S-layer protein N-terminus. In addition, a degenerate primer pair 
(Usl-1  and  Usl-2)  was  used  to  amplify  the  partial  S-layer  protein  gene  from  LAB20  (Jakava-
Viljanen and Palva 2007). Then, the sequence was completed using inverse PCR. The predicted 
open reading frame (ORF) and other gene elements are described in Study II. In general, amino acid 
sequences of S-layer proteins in related species are remarkably similar (Hynönen and Palva 2013b, 
Hagen et al. 2005). Comparison to other Lactobacillus S-layer protein sequences (Fig. S1 of Study 
II) demonstrated that LAB20’s S-layer protein is novel. The ClustalW multiple alignment program 
revealed higher levels of similarity in the signal peptide and C-terminal regions, which are predicted 
to anchor the protein to the bacterial cell wall. Great variability was observed in the N-terminal 
region, which is responsible for interactions with the environment (Smit et al. 2001, Hynönen and 
Palva  2013b).  The  S-layer  protein  of  LAB20  clustered  with  the  S-layer  proteins  of  L. crispatus 
MH315 and L. acidophilus 30SC. 
2.2. Electron microscopy images of LAB20 (Unpublished) 
To visualize the surface structure of LAB20, cells from an overnight culture were studied using 
electron microscopy (EM). Negative staining revealed an interesting tube-like structure in the 
LAB20 cell  wall  (Fig.  3). However, this structure was rarely present, indicating that it may form 
only under certain circumstances. It is possible that LAB20 cells use these structures to 
communicate, as they were present in cells in contact with one another. Alternatively, the cells may 
have responded to some stimulus by secreting substances, suggested by the higher density at the tip 
of the tube. Further investigation is needed to learn more about the formation and function of this 
tube-like structure. 
 
 
Figure.  3 EM  images  of  negative-
stained LAB20 cells. Tube-like 
structure (arrows) was found in two 
cells in close contact (A). An enlarged 
view of the tube-like structure is 
shown in panel B. The scale bar in 
panel A represents 200 nm, and that in 
panel B represents 50 nm.   
 
 
 
 
 
29
    TEM was used to visualize cellular structures in the LAB20 cell wall. The cell wall was coated in 
an S-layer protein envelope (Fig. 4), revealed upon further study to consist of novel S-layer proteins 
(chapter 2.1). In addition, the outermost structure of the LAB20 cell was found to be a putative 
extracellular polysaccharide (EPS) layer. This EPS layer was thicker when cell were grown at low 
pH (pH 5.0 vs.  optimized pH 7.0 culture conditions).  It  has been reported that environmental  stress 
leads to various changes in gene expression facilitating a cell’s adaptation to its environment (Lebeer 
et al. 2008). Many resistance mechanisms arise from changes in lactobacillar cell surface structures, 
which contribute to maintaining cell integrity under stressful conditions (Sengupta et al. 2013). With 
regard to the role of EPS in stress resistance, microarray expression analyses indicate that L. 
acidophilus and L. reuteri genes involved in EPS biosynthesis are suppressed after exposure to bile, 
however, the underlying mechanism remains unclear (Whitehead et al. 2008, Pfeiler et al. 2007). In 
the dairy industry, EPS from lactic acid bacteria could improve the viscosity and texture of 
fermentation products. Therefore, many studies aimed at optimizing the production of lactobacillar 
EPS have been performed. Optimum lactobacillar EPS production is typically observed under acidic 
conditions,  in  the  range  of  pH 4.0  to  5.8  (Mozzi  et  al.  2003,  van  den  Berg  et  al.  1995).  Consistent  
with these studies, LAB20’s EPS layer was thicker in an acidic culture. Generally, EPS mediates 
interactions between lactobacilli and the environment and promotes bacterial adhesion and biofilm 
formation (Sengupta et al. 2013), its role in responding to acid pressure is less clear. 
 
 
Figure 4. TEM images of 
LAB20 cells grown in mLBS 
medium  at  (A)  pH  5  and  (B)  
pH 7. The S-layer protein 
envelope was present in 
LAB20 cells grown under both 
conditions (arrow heads). The 
extracelluar polysaccharide 
layer (arrows) was thicker at 
pH  5.  The  scale  bar  in  the  
panels represents 100 nm. 
 
3. Strain-specific detection of LAB20 in dog feces (II, III) 
3.1. Real-time PCR assay development 
A  real-time  PCR  assay  to  detect  LAB20  on  strain  level  was  developed,  and  validated  in  a  
preliminary dog feeding study. A strain-specific primer set was constructed and targeted to the 
variable region of the novel LAB20 S-layer protein gene. This variable region is located 85 amino 
acid (aa) after the LAB20 signal sequence, and primer pair RT1 and RT2 generates a 163 base pair 
(bp) amplicon. The specificity of these primers was verified by comparing the target sequence in 
GenBank, and using 11 Lactobacillus strains phylogenetical closely and distantly related to LAB20 
as PCR templates. Null results for both indicate that the primer pair targets to LAB20 specifically. 
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  To further validate the detection assay, an intervention study was conducted to detect LAB20 in 
dog  feces.  Fermented  milk  containing  LAB20  was  fed  to  a  single  domestic  dog  as  a  food  
supplement for 5 days. Its feces were collected over the feeding period and the 6 weeks that 
followed. Prior to LAB20 exposure, the primer pair detected 100.59 DNA copies g-1 in the feces, and 
LAB20 counts peaked after the third feeding, at 107.20 copies g-1. Preliminary 454 sequencing data 
indicates there is a single copy of the S-layer protein gene in the LAB20 genome. Therefore, 
targeting it could generate more reliable results than targeting a multicopy gene, such as the one for 
16s rRNA (Masco et al. 2007). Interestingly, LAB20 was detected from fecal sample even 6 weeks 
post-administration, which indicates that this strain can persist in the dog gut for a reasonably long 
period. By contrast, many probiotic intervention studies have reported shorter persistence periods, 
from 3 days to 5 weeks post-administration (Manninen et al. 2006). Because most probiotic strains 
fail to persist in the gut, probiotic products should contain very high numbers of bacterial to 
compensate. Therefore, a probiotic with a reasonable persistence period could be meaningful, not 
only to reduce the frequency of ingestion required, but also because it implies that the probiotic 
strain can adapt and thrive in the GIT. 
3.2. Dog intervention study 
To determine if LAB20 could transit through and persist in the dog gut, five pet dogs raised in 
different families were included in an intervention study. A previously developed, strain-specific 
real-time PCR assay was used to detect LAB20 in fecal samples. The baseline for real-time PCR 
detection varied from 0 to 102.98 copies  g-1 in dog feces. By feeding days 2 and 3, significantly 
higher numbers of LAB20 was detected in fecal samples. However, these numbers dropped to 
baseline levels after feeding ceased. This result  is  not consistent with the findings of the previous 
dog  assay,  in  which  LAB20  was  able  to  persist  in  the  dog  gut  6  weeks  post-administration  (II).  
However, in this intervention study, fewer LAB20 cells (108 CFU vs. 5×108 CFU) were fed to dogs 
over a shorter feeding period (3 days vs. 5 days). Without access to biopsy samples from pet dogs, it 
was difficult to determine whether LAB20 was unable to colonize in the canine gut, or because it 
colonized the canine gut but was not shed in the feces in high numbers.  
  Thus  far,  most  putative  probiotic  isolates  have  not  been  able  to  persist  in  recipients’  guts  after  
administration ends (Weese and Anderson 2002, Manichanh et al. 2010). Apparently, the microbial 
ecosystem is rather stable, reflecting host adaptation over time. Additionally, a unique individual 
gut microbiome develops as a result of the host’s genetic background, immune responses, and 
dietary preferences (Roessler et al. 2008, Turnbaugh et al. 2009, Bron et al. 2011). Thus, it is 
difficult for a bacterial strain to gain a foothold in the pre-existing microbial ecosystem. However, 
in a previous study (I), we found that LAB20 was dominant in the guts of five dogs. This may 
indicate that LAB20 is a canine commensal bacterium, able to adapt in different dogs. Therefore, 
the mechanisms underlying the ability of LAB20 to adhere to the canine gut mucosa are of 
particular interest.  
  Most putative canine probiotics have been isolated from dog feces (Biagi et al. 2007, Manninen et 
al. 2006, Strompfová et al. 2004). In one study, isolates from dog colon commensal bacteria were 
studied, but only B. animalis AHC7 was selected for dog intervention study, because it could transit 
the murine GIT in high numbers. The results indicated that B. animalis AHC7 consumption could 
 
 
 
 
31
improve canine GI health by reducing Clostridia carriage (O'Mahony et al. 2009). Endogenous 
strains are interesting to investigate, not only because they may adapt and thrive better than isolates 
from dog feces, but also because they influence other commensal microbes and the host immune 
response. It has been reported that commensal bacteria can influence their neighbors via direct 
inhibition, competition activity, or their metabolism products, thus shaping microbial ecology in the 
host gut (Vacharaksa and Finlay 2010). The small intestine accounts for a large proportion of the 
immunomodulatory capacity of the body, and the population size of endogenous microbiota is 
relatively small at this site (Bron et al. 2011). Therefore, LAB20, which is dominant in the canine 
jejunum, could potentially benefit the host by modulating the host immune response.  
4. LAB20 cells adhere to mucus, Caco-2 and HT-29 cell lines and regulate lipopolysaccharide-
induced interleukin-8 production (IV) 
4.1. Adhesion to mucus of different origins 
Mucus is the protective layer for underlying epithelium and contains mucin glycoproteins and 
diverse antimicrobial molecules. The viscous mucus layer is continually renewed to resist microbial 
passage; meanwhile, it provides epitopes for bacterial adhesion (McGuckin et al. 2011). The 
adhesion ability of LAB20 was test using mucus samples collected from different sources (canine 
duodenum, jejunum, ileum, cecum, and colon; and porcine and human colon). LAB20’s adhesion to 
canine colonic mucus was significant greater (P < 0.05) than its adhesion to other types of mucus 
(Fig.2 in Study IV). By contrast, the human-derived strain L. rhamnosus GG adhered best to human 
mucus  (P < 0.05). This indicates that mucus adhesion efficiency of bacteria may correlate to a 
specific host.  
    To study the impact of EPS on LAB20’s mucus adhesion, a LAB20 EPS mutant (SAA658) was 
constructed by cloning an overlapping partial epsE gene and S-layer promoter region into the 
pLEB579 vector and transforming it into competent LAB20 cells. An antisense RNA strategy was 
used, since creating a knockout mutant was not possible due to the low transformation efficiency of 
LAB20. SAA658 showed reduced adhesion to all mucus samples relative to the LAB20 wild-type 
strain. This suggests that EPS could potentially modulate the adhesion of LAB20 to mucus.  
    Various mucins constitute the main components of mucus. The complex oligosaccharides arrays 
on the central glycosylated domains of mucins represent multiple potential ligands for microbial 
adhesion. The expression of glycosyltransferases differs between various GIT and can be modulated 
by the innate and adaptive immune responses (McGuckin et al. 2011). In addition to mucins, 
proteomic studies have shown that a large number of proteins add complexity to mucus (Johansson 
et al. 2009). The complexity and variable composition of mucus may explain the varying adhesion 
efficiency of LAB20 to canine mucus from various intestinal compartments. 
4.2. Adhesion to epithelial cells 
Caco-2 and HT-29 cells are derived from human colon adenocarcinomas. They are widely used as 
in vitro models  for  studying  the  adhesion  of  bacteria  to  GIT  epithelial  cells.  The  HT-29  cell  line  
differs from the Caco-2 cell line in that it contains a small proportion (<5%) of mucus-secreting and 
columnar absorptive cells (Gagnon et al. 2013, Huet et al. 1995). The adherence of LAB20 and 
SAA658 to Caco-2 and HT-29 cells at different growth stages was included. For both strains, 
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adhesion was more efficient with 21-day-old than 3-day and 8-day old HT-29 and Caco-2 (Fig.3 in 
Study IV). Wild-type LAB20 displayed significantly higher adhesion than the EPS mutant SAA658 
(P < 0.05). The putative EPS modifications in SAA658 could be responsible for its reduced 
adhesion to epithelial cells. However, manipulation of the outermost bacterial polysaccharide layer 
may also impact the presentation of surface proteins, which have the potential to bind to epithelial 
cells (Schneitz et al. 1993). 
4.3. Attenuation assay 
To investigate the potential probiotic effects of LAB20, lipopolysaccharide (LPS) induced 
interleukin-8 (IL-8) production was evaluated by incubating LAB20 with HT-29 cells. IL-8 is a pro-
inflammatory chemokine that recruits neutrophils into the mucosa (Mitsuyama et al. 1994). The 
result showed that IL-8 expression in HT-29 cells was attenuated in the presence of LAB20 (Fig. 2 
of Study IV) and displayed significant (P < 0.05) reduction in higher LPS stimulation. Culture 
medium, freeze-dried LAB20, and the EPS mutant strain SAA658 were employed as controls, 
either no or reduced attenuation of IL-8 expression was observed for these controls. The fact that 
IL-8 was not reduced by exposure to freeze-dried cells suggests that IL-8 attenuation is associated 
with LAB20 bacterial structures or metabolic products. To study the role of LAB20’s putative EPS 
layer in IL-8 attenuation (Fig. 1 of Study IV, panel A), strain SAA658 was constructed using 
antisense RNA to alter EPS production in LAB20 cells. Although EPS was not eliminated in 
SAA658, the appearance of the putative EPS layer adjunct to the cell wall was modified (Fig. 1 of 
Study IV, panel B). The reduced IL-8 attenuation associated with SAA658 implies that the EPS 
structure of LAB20 may be responsible for the reduction in IL-8. SAA658 also displayed a 
significantly reduced ability to adhere; therefore, the reduction in IL-8 attenuation associated with 
SAA658 may attributable to reduced adhesion and interaction with HT-29 cells. Several studies 
have showed that bifidobacteria and lactobacilli can reduce the severity of inflammation in rodent 
models and patients with IBD (Madsen et al. 2001, McCarthy et al. 2003, Claes et al. 2011), but 
anti-inflammatory properties vary among strains.  
Probiotic candidates are exploited for their anti-inflammatory and immunoregulatory effects, 
which influence enteric infections and mucosal inflammation. L. paracasei CNCM I-4034 and its 
supernatant have been found to reduce the production of Salmonella typhi-induced IL-6, IL-8, IL-
12p70, and tumor necrosis factor ? (TNF-?) in human intestinal DCs (Bermudez-Brito et al. 2012). 
In an IBD animal model, the anti-inflammatory effects of L. delbrueckii subsp. lactis CNRZ327 
result from modulation of the production of  transforming growth factor ? (TGF-?), IL-6, and IL-12 
in colonic tissue (Santos Rocha et al. 2014). These results provide insight into treating IBD with 
probiotic bacteria that modulate cytokine production. Based on our findings, the probiotic candidate 
LAB20 has the potential to decrease IL-8 production in inflammation. 
5. Transcription level changes of Mub, Fbp, and S-layer protein genes during co-incubation 
with porcine mucin (Unpublished) 
It has been reported that multiple cell surface proteins contribute to bacterial adhesion to intestinal 
cells in vitro. For instance, L. acidophilus NCFM’s fibronectin-binding protein (Fbp), mucus-
binding protein (Mub), and S-layer protein are involved in adhesion to Caco-2 cells (Buck et al. 
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2005). However, exposure to bile and acid stress in vivo could alter the bacterial surface structures. 
To investigate whether mucin influences the transcription of genes associated with mucus binding, 
LAB20 was co-cultured with 0, 0.05 and 0.25% porcine mucin. The expression of Mub was 
significantly down-regulated (P < 0.05) in both the 0.05% and 0.25% mucin cultures; S-layer 
protein gene transcription also decreased in the presence of mucin, but only significantly in the 0.25% 
culture. Expression of Fbp was up-regulated in 0.05% mucin and significantly down-regulated in 
0.25% mucin (Fig.  5). This suggests that mucin present in the GIT may mediate transcription of 
genes associated with mucus binding. Therefore, the presence of mucin may affect LAB20 adhesion 
in vivo.  
 
 
Figure 5. Expressioin of the LAB20 Mub, Fbp and S-layer protein genes when co-cultured with mucin (0, 
0.05, or 0.25%). The values represent the fold change in expression relative to LAB20 cells grown without 
mucin (set at 1.00). Expression of target genes was normalized to expression of the 16S rRNA gene. The 
results  of  three  technical  replicates  with  three  parallels  are  expressed  as  means  ±  standard  deviations.  
Statistically significant differences are indicated with an asterisk (P < 0.05). 
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Conclusion 
 
In this study, facultative Lactobacillus strains were found abundant in the jejunal microbiota of five 
fistulated beagles, and L. acidophilus was dominant.  LAB20, the strain with the most common L. 
acidophilus rep-PCR fingerprint, was selected as a representative strain, and we investigated the 
chariacteristics contributing to its abundance in the canine small intestine. This strain was found to 
grow poorly in vitro; therefore, its growth was optimized by raising the pH of the culture medium to 
7.0. Using TEM, SDS-PAGE, and N-terminal sequencing, a novel S-layer protein was identified in 
LAB20. In addition, a real-time PCR assay specifically targeted to LAB20 was developed, enabling 
the detection and quantification of this strain.  In one dog intervention study that included a single 
animal,  the  strain-specific  detection  was  verified,  and  LAB20  was  found  to  persist  in  the  dog  
intestine over 6 weeks after the probiotic feeding period had ended. In another intervention study 
that included five dogs, high LAB20 counts were found only during the feeding period. Fecal 
sample plating revealed that LAB20 is able to survive passage through the canine intestine. We also 
found its colony morphotype was distinct from that of other lactobacilli. LAB20 adhered to mucus 
and epithelial cells and elicited an anti-inflammatory response in HT-29 cells. Both adhesion and 
IL-8 attenuation in intestinal epithelial cells appeared to be associated with bacterial EPS. Our 
results indicate that LAB20 has potential as a canine probiotic candidate with anti-inflammatory 
property, the capacity to adhere to mucus and intestinal cell lines, and the ability to survive passage 
through the GIT.  
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